| Recruiting | ALG-LungCancerRegistry (SAFRO2202) NCT07161882 | Société Algérienne de Formation et de Recherche en Oncologie | — |
| Recruiting | Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring NCT05500391 | Centre Oscar Lambret | Phase 2 |
| Completed | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430 | Travera Inc | — |
| Completed | IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer NCT04854590 | AstraZeneca | — |
| Active Not Recruiting | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors NCT04660929 | Carisma Therapeutics Inc | Phase 1 |
| Completed | M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers NCT03554473 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer NCT02675088 | Chinese Academy of Medical Sciences | N/A |
| Active Not Recruiting | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers NCT03212404 | Checkpoint Therapeutics, Inc. | Phase 1 |
| Completed | A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer NCT03092739 | Hoffmann-La Roche | — |
| Terminated | TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) NCT02608411 | Istituto Oncologico Veneto IRCCS | Phase 2 |
| Unknown | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC NCT02688036 | Chinese Academy of Medical Sciences | Phase 3 |
| Unknown | Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a P NCT02366741 | Sheba Medical Center | N/A |
| Terminated | Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma NCT02034123 | GlaxoSmithKline | Phase 1 |
| Unknown | Temozolomide as Maintenance Therapy in Small Cell Lung Cancer NCT01900951 | Chinese PLA General Hospital | Phase 2 |
| Completed | Study of Arsenic Trioxide in Small Cell Lung Cancer NCT01470248 | Emory University | Phase 2 |
| Completed | A Phase I Study of iPS Cell Generation From Patients With COPD NCT01860898 | Mayo Clinic | N/A |
| Completed | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient NCT00826644 | Chonnam National University Hospital | Phase 3 |
| Terminated | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administ NCT00537511 | Celgene | Phase 1 / Phase 2 |
| Completed | BI 2536 Second Line Monotherapy in SCLC NCT00412880 | Boehringer Ingelheim | Phase 2 |
| Terminated | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy NCT00447421 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Completed | A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer NCT00359359 | Bayer | Phase 1 / Phase 2 |
| Completed | Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer NCT00305942 | SCRI Development Innovations, LLC | Phase 2 |
| Completed | Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer NCT00294190 | SCRI Development Innovations, LLC | Phase 2 |
| Completed | Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer NCT00298896 | Sunesis Pharmaceuticals | Phase 2 |
| Completed | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer NCT00284154 | SCRI Development Innovations, LLC | Phase 2 |
| Terminated | Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cance NCT00129974 | Tufts Medical Center | Phase 2 |
| Terminated | Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) NCT00324558 | Clinica Universidad de Navarra, Universidad de Navarra | Phase 2 |
| Terminated | Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum NCT00094978 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned NCT00191750 | Eli Lilly and Company | Phase 2 |
| Unknown | Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy NCT00100256 | Andarix Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer NCT00126828 | AHS Cancer Control Alberta | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer NCT00046787 | Astellas Pharma Inc | Phase 2 |